Study 3: STEP 5 Trial Duration : 104 weeks (2 years) Findings : Participants on semaglutide lost an average of 15.2% of their body weight, compared to 2.6% in the placebo group
Arble DM, Bass J, Laposky AD, Vitaterna MH, Turek FW
Frequently Asked Questions Is It Safe To Microdose Semaglutide
Concurrent medications can interfere with semaglutide's effects
Those differences trace back to molecular structure, which determines everything downstream
In the two-year SUSTAIN 6 trial, semaglutide significantly reduced the risk of the occurrence of a three-component MACE endpoint consisting of cardiovascular death, non-fatal heart attack or non-fatal stroke